Clinical Trials Week
Susan Hasty, Publisher
Table of Contents . . . February 3rd, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Clinical Trials Week | Other Publications
Adoptive Immunotherapy - Superficial bladder cancer treated with macrophage-activated killer cells
Tobacco Use - Advance, marketed for "reduced exposure" for smokers has potential
Chronic Plaque Psoriasis - Efficacy and tolerability of alefacept is promising for many patients
Colon Cancer - Cytotoxic solution used for rectal washout can be extended to the whole colon
Colorectal Cancer - Peritoneal carcinomatosis cases have generally poor prognosis
Ethics - New accreditation program announced for human research trials
Sentinel Lymph Nodes - Localization using MR angiography using gadomer-17 feasible
Abdominal Aortic Aneurysms - Progress in advancements of cardiovascular disease therapies announced
Allergic Airway Disease - Bronchial cells upregulate receptor CXCR4, respond better to SDF-1alpha
Angina - Data demonstrates long term efficacy of CardioGenesis TMR
Appointments - Former WebMD executive producer joins NewsRx
Atherosclerosis - MRLI gains rights to conduct clinical trials for implitapide
Aton Pharma, Inc. - $13.7M equity financing closed
Boston Scientific Corp. - Carignan named medical director, vice president of clinical affairs
Chronic Bronchitis - FDA panel recommends approval of Ketek for respiratory tract infections
Clinical Trials - PHT Corp. announces ISO 9001:2000 registration
Crohn Disease - Remicade granted priority review by FDA for use in maintaining fistula closure
Diagnostic Testing - Parexel enters collaboration to co-market clinical trials services
Drug Development - Company asks FDA to reactivate INDA for IL-12
Drug Development - Development of ETRX 101 discontinued
Electronic Data Capture - Technology helps to deliver comprehensive infrastructure for clinical trials
Finance - Orphan Medical reiterates record 2002 revenue guidance, provides positive outlook
Fluoroquinolone Resistance - Risk factors need to be recognized into order to curb rise
Glomerulosclerosis - Adolescent LD transplantation should be based on factors besides graft survival
Left Ventricular Dysfunction - FDA advisory committee recommends use of Coreg, based on CAPRICORN study
Lung Cancer - Phase III trial of Xcytrin receives special protocol assessment agreement
Macular Degeneration - VisionCare begins enrollment of implantable miniature telescope pivotal trial
Melanoma - Positive clinical data from melanoma cancer vaccine trial announced
Mergers and Acquisitions - Mera Pharmaceuticals to acquire botanical drug development company
Myocardial Injury - i-STAT commences troponin I clinical trials
Parkinson Disease - Newron releases positive preliminary phase II data for safinamide
Pediatric Renal Transplant - Graft rejection outcomes highest in infants and adolescents
Peregrine Pharmaceuticals, Inc. - Company cuts clinical staff
Perinatal Medicine - S100B protein in biological fluids may be diagnostic tool for brain damage
Pharsight Corp. - Roche joins roster of PKS customers
Prostate Cancer - Update provided on clinical pipeline
Respiratory Infections - Phase II study of amikacin will soon start in patients on mechanical ventilators
Rheumatoid Arthritis - Leukocyte migration inhibited by nonpeptide antagonist of CXCR2
Rheumatoid Arthritis - Progress announced with p38 MAP kinase program
Rheumatology - Biologic response modifiers show progress against RA
Staph Infection - Inhibitex initiates phase II trial for Veronate
Stroke - HuEP5C7, a monoclonal anti-E/P-selectin, may be a viable treatment option
Subepidermal Bullous Dermatosis - Few patients with IgA-EBA showed scarring, therapy-resistant ocular symptoms
Systemic Lupus Erythematosus - Confirmatory phase III trial for Prestara initiated
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
